» Articles » PMID: 25246114

Gonadotrophin-releasing Hormone Agonist Trigger and Freeze-all Strategy Does Not Prevent Severe Ovarian Hyperstimulation Syndrome: a Report of Three Cases

Overview
Publisher Elsevier
Date 2014 Sep 24
PMID 25246114
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Ovarian hyperstimulation syndrome (OHSS) is the most serious iatrogenic complication of IVF cycles. Although the development of effective treatment strategies for this syndrome is important, preventing OHSS is more crucial. Triggering ovulation with a gonadotrophin-releasing hormone (GnRH) agonist is one method used to avoid OHSS. In this paper, three patients who developed severe OHSS after undergoing GnRH agonist triggering and freezing of all embryos in a GnRH antagonist protocol are described. A review of the literature is also provided. This report highlights the ongoing risk of severe OHSS even after GnRH agonist triggering combined with freezing all embryos in GnRH antagonist cycles. Other prevention strategies might be considered for extreme hyper-responders.

Citing Articles

Efficacy of Local N-Acetylcysteine Administration in Mitigating OHSS Parameters: A Comparative Analysis With Dopaminergic Agonist in the OHSS Model.

Letras-Luna D, Rosas-Murrieta N, Pazos-Salazar N, Flores-Hernandez J, Castelan F, Venegas B Int J Endocrinol. 2024; 2024:1634072.

PMID: 39669379 PMC: 11637629. DOI: 10.1155/ije/1634072.


Severe ovarian hyperstimulation syndrome following sole gonadotropin-releasing hormone (GnRH) agonist trigger: a case series and literature review.

Berkovitz-Shperling R, Samara N, Meir R, Dominsky O, Azam F, Feferkorn I Arch Gynecol Obstet. 2024; 310(5):2297-2304.

PMID: 39302412 PMC: 11485447. DOI: 10.1007/s00404-024-07740-7.


Severe ovarian hyperstimulation syndrome in an oocyte donor despite preventive strategies.

Forgiarini A, Contreras M, Bonta S, Maggi S, Espinel L Clin Exp Reprod Med. 2024; 52(1):101-105.

PMID: 39039638 PMC: 11900659. DOI: 10.5653/cerm.2024.06884.


Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review.

Ingold C, Navarro P, de Oliveira R, Barbosa C, Bedoschi G Ther Adv Reprod Health. 2023; 17:26334941231196545.

PMID: 37674690 PMC: 10478554. DOI: 10.1177/26334941231196545.


Severe Ovarian Hyperstimulation Syndrome in a Woman With Breast Cancer Under Letrozole Triggered With GnRH Agonist: A Case Report and Review of the Literature.

Iorio G, Rovetto M, Conforti A, Carbone L, Vallone R, Cariati F Front Reprod Health. 2022; 3:704153.

PMID: 36303992 PMC: 9580822. DOI: 10.3389/frph.2021.704153.